Conference to convene gene- and cell-therapy thought leaders from the research, industry, and capital communities as well as representatives from regulatory bodies
PISCATAWAY, N.J., Dec. 14, 2023.
The recent announcement, delivered at the American Society of Gene & Cell Therapy’s (ASGCT) 25th annual meeting, cements GenScript’s position as the leading provider of non-viral homology-directed repair (HDR) template solutions for immune-cell engineering.